Posts Tagged ‘National Institutes of Health’

Supporting Americans with Disabilities

We applaud the Obama White House for its continuing support of individuals with disabilities. Through the stimulus act, the administration committed additional funds to autism research, on top of the existing National Institutes of Health funding and Combating Autism Act funding.

Kareem Dale, Special Assistant to the President for Disability Policy, blogged yesterday about another move the administration made to support those with disabilities. Read more here in his White House blog. We applaud all their efforts to move the disability agenda ahead and we look forward to seeing what’s around the next corner for autism.

The Autism Advocacy Community Finds Common Ground at a Meeting with Francis Collins

February 8, 2010 Leave a comment

By Geri Dawson, Chief Science Officer, Autism Speaks

This week, an unprecedented gathering of the autism advocacy community was held at the National Institutes of Health. Francis Collins, director of the nation’s largest agency focused on science and public health, met with members of diverse factions of the autism community to listen to their priorities and perspectives. As Collins noted early on in the meeting, the strife among the members of the autism community is “legendary,” sometimes scaring members of the scientific community who often will instead choose to study less controversial conditions. Not surprisingly, opinions expressed at the table were indeed diverse, ranging from those who believe that autism is caused by toxins in our environment and advocate that NIH’s efforts should be targeted on prevention to those who believe that autism shouldn’t even be considered a disorder and efforts should be directed instead at improving the quality of life of persons with autism spectrum disorder. Remarkably, however, finding common ground among the autism community became the theme of the meeting.

As different members of the community passionately spoke about the suffering of people with autism and their families and the urgency with which the NIH needs to respond to the autism public health crisis, it became clear that a large part of the divisiveness among the autism community is the result of the tremendous heterogeneity in the condition. Some who spoke were parents of children with autism who are nonverbal and suffer from debilitating medical conditions, such as GI problems and seizures, whereas others who spoke were persons with autism spectrum disorder themselves, who were able to eloquently describe the need for greater acceptance of persons on the autism spectrum. And while there remained significant differences of opinion regarding where NIH should direct its resources – whether on prevention, causes, more effective treatments, or services – the common sentiment emerged that our unified goal is to relieve the burden of autism in all of its forms and manifestations. Furthermore, there was a shared sense of urgency and recognition that the NIH needs to be more aggressive, coordinated, and directive in its pursuit of scientific discoveries that will have real impact on the lives of persons with autism spectrum disorder and their families.

The meeting ended with a few words of advice from the director of NIH. He suggested that the autism advocacy community will be more effective the more we find common ground. He noted that while there are real differences of opinion, we are all on the same team and we should remember to “respect the person while challenging the idea.” He urged the autism community to hold the NIH accountable. And finally, he talked about the importance of bringing together the basic scientists with people suffering from autism, noting that this personal connection made a difference in his own career and can be highly motivating for scientists, many of whom are trying to make a real difference in the world.

I personally left the meeting feeling more hopeful that the autism community can indeed work more respectfully and productively together by finding common ground. I believe that a unified voice will be critical for holding NIH accountable. Because of the scale of the public health crisis we face, we urgently need more scientific resources devoted to our cause. Together, we can make it happen.

Geraldine Dawson became Autism Speaks’ first chief science officer in January of 2008. In this role, Dawson serves as the scientific leader of Autism Speaks, working with the scientific community, stakeholders, and science staff, to shape, expand, and communicate the foundation’s scientific vision and strategy. Dawson is also Research Professor of Psychiatry at the University of North Carolina at Chapel Hill.


Get every new post delivered to your Inbox.

Join 1,105 other followers

%d bloggers like this: